Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

[1]  L. Zitvogel,et al.  Trial Watch—Oncolytic viruses and cancer therapy , 2016, Oncoimmunology.

[2]  L. Galluzzi,et al.  First oncolytic virus approved for melanoma immunotherapy , 2016, Oncoimmunology.

[3]  S. Russell,et al.  MicroRNAs and oncolytic viruses. , 2015, Current opinion in virology.

[4]  D. Jäger,et al.  MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus , 2014, Cancer Gene Therapy.

[5]  C. Breitbach,et al.  Going viral with cancer immunotherapy , 2014, Nature Reviews Cancer.

[6]  D. Edbauer,et al.  Good guy or bad guy: the opposing roles of microRNA 125b in cancer , 2014, Cell Communication and Signaling.

[7]  A. Baruzzi,et al.  Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III , 2014, Molecular oncology.

[8]  R. Cattaneo,et al.  New viruses for cancer therapy: meeting clinical needs , 2013, Nature Reviews Microbiology.

[9]  L. Zitvogel,et al.  Trial Watch-Oncolytic viruses and cancer therapy. , 2016 .

[10]  C. Croce,et al.  The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. , 2012, Blood.

[11]  C. von Kalle,et al.  MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Na Li,et al.  Comprehensive survey of human brain microRNA by deep sequencing , 2010, BMC Genomics.

[13]  S. Russell,et al.  MicroRNAs and the regulation of vector tropism. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[15]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[16]  S. Russell,et al.  Engineering microRNA responsiveness to decrease virus pathogenicity , 2008, Nature Medicine.

[17]  R. Andino,et al.  Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA , 2008, Journal of Virology.

[18]  H. Atkins,et al.  A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Yunqing Li,et al.  microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.

[20]  R. Cattaneo,et al.  Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. , 2007, Cancer research.

[21]  A. Bohm,et al.  Mechanism of poly(A) polymerase: structure of the enzyme-MgATP-RNA ternary complex and kinetic analysis. , 2007, Structure.

[22]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[23]  S. Russell,et al.  History of oncolytic viruses: genesis to genetic engineering. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  P. Staeheli,et al.  RNA Polymerase II-Controlled Expression of Antigenomic RNA Enhances the Rescue Efficacies of Two Different Members of the Mononegavirales Independently of the Site of Viral Genome Replication , 2006, Journal of Virology.

[25]  D. Gerlier,et al.  Dynamics of Viral RNA Synthesis during Measles Virus Infection , 2005, Journal of Virology.

[26]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[27]  M. Billeter,et al.  Rescue of measles viruses from cloned DNA. , 1995, The EMBO journal.

[28]  M. Billeter,et al.  Altered transcription of a defective measles virus genome derived from a diseased human brain. , 1987, The EMBO journal.

[29]  L. Zitvogel,et al.  Trial watch , 2013, Oncoimmunology.

[30]  J. Diallo,et al.  Intelligent design: combination therapy with oncolytic viruses. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  W. P. Duprex,et al.  The measles virus replication cycle. , 2009, Current topics in microbiology and immunology.

[32]  S. Russell,et al.  Measles virus for cancer therapy. , 2009, Current topics in microbiology and immunology.

[33]  S. Whelan,et al.  Transcription and replication of nonsegmented negative-strand RNA viruses. , 2004, Current topics in microbiology and immunology.